Pandemic Influenza - PowerPoint PPT Presentation

1 / 51
About This Presentation
Title:

Pandemic Influenza

Description:

Caused by influenza viruses that occur naturally among wild birds. ... Generally not ascertained. Direct/indirect contact with migratory waterfowl. Spread ... – PowerPoint PPT presentation

Number of Views:45
Avg rating:3.0/5.0
Slides: 52
Provided by: Tyna9
Category:

less

Transcript and Presenter's Notes

Title: Pandemic Influenza


1
Pandemic Influenza
  • John Wilgis, MBA RRT
  • Florida Hospital Association
  • Director, Emergency Management Services

2
  • Is it here yet?

3
Influenza Definitions
  • Seasonal Flu
  • Respiratory illness that can be transmitted
    person to person. Most people have some immunity,
    and a vaccine is available.
  • Avian Flu
  • Caused by influenza viruses that occur naturally
    among wild birds. Low pathogenic is common in
    birds and causes few problems. Highly pathogenic
    H5N1 is deadly to domestic fowl, can be
    transmitted from birds to humans, and is deadly
    to humans. There is virtually no human immunity
    and human vaccine availability is very limited.
  • Pandemic Flu
  • Virulent human flu that causes a global outbreak,
    or pandemic, of serious illness. Because there is
    little natural immunity, the disease can spread
    easily from person to person. Currently, there is
    no pandemic flu.

4
Influenza Differences
  • Seasonal Pandemic
  • Yearly Rarely
  • Familiar virus New virus
  • Mild/moderate Severe symptoms
  • symptoms
  • Very young, very old, Healthy people
  • health problems
  • Vaccine available No vaccine

5
Human Influenza
  • Seasonal influenza
  • Three types A, B, and C
  • Three influenza viruses currently circulate
    worldwide
  • 2 type A strains (currently H1N1 and H3N2)
  • 1 type B strain
  • Adults may have partial immunity (protection) to
    seasonal flu
  • Have had past infections with related flu
    viruses
  • No pre-existing immunity to a new virus that is
    dramatically different from past viruses

6
Human Influenza Transmission
  • Influenza spreads readily from person to person
  • Primarily thought to spread by respiratory
    droplets
  • Lesser role for airborne spread and indirect
    contact
  • May be transmitted from infected persons who
    appear well (asymptomatic trans)
  • Short incubation period average 2 days (range
    1-4 days)
  • May be spread 24 hours before onset of symptoms
    and during the symptomatic period

7
Avian Influenza A (H5N1)
  • Why are we so concerned about Avian Influenza A
    (Bird flu, H5N1)?
  • Unprecedented dissemination in birds
  • Direct spread from domestic birds to humans
  • Strains (2003) resistant to amantadine and
    rimantadine possibly oseltamivir
  • Threat of human pandemic

8
What Do the H and N Mean?
Proteins on the surface of the virus
Neuraminidase (NA) (9 types exist in nature)
  • Hemagglutinin (HA)
  • (16 types exist in nature)

Genes
9
Epizootiology - Birds
  • Natural Hosts
  • Domestic fowl, ducks, geese, turkeys, guinea
    fowl, quail, and pheasants
  • Source of Infection
  • Generally not ascertained
  • Direct/indirect contact with migratory waterfowl
  • Spread
  • Rapid in flocks by direct contact
  • Viral shed in feces and nasal and ocular
    discharges

10
H5N1 History and Evolution
Key epidemiological findings
  • Nomadic or free-range ducks
  • Contact wild waterbirds
  • Virus shedding and spreading
  • Reservoir of infection
  • Live bird markets
  • Cultural practices

11
(No Transcript)
12
Exposure to Avian Influenza
13
Exposure to Avian Influenza
14
Current Outbreak Avian Influenza A (H5N1)
  • All cases involved close contact with infected
    poultry or ill family members.
  • No sustained person-to-person transmission.
  • Mortality rate is high in human avian flu
    infections.
  • Remains very difficult for humans to get.
  • Is still a disease of birds.

15
Current Outbreak Avian Influenza A (H5N1)
  • Human Deaths
  • 385 cases, 243 deaths (63.1 Case Fatality Rate)
  • 15 countries
  • Bird Deaths
  • 150 200 million bird deaths
  • gt50 countries (Asia, Europe, Africa)

WHO, 19 June 2008
16
(No Transcript)
17
Current OutbreakAvian Influenza A (H5N1)
  • There is NO current human influenza pandemic
  • The US and many other countries are preparing for
    a possible severe influenza pandemic because
  • The avian influenza (bird flu) outbreak is
    widespread and not able to be controlled.
  • The virus can infect humans and cause severe
    illness.
  • An avian influenza virus evolved to cause a
    catastrophic human pandemic in 1918.

18
Pandemic Threat
  • Three Requirements for a Pandemic
  • Novel virus -- no immunity in human population
  • Virus infects humans causing serious illness
  • Sustained person-to-person transmission

19
Pandemic Influenza
  • A new strain of influenza can evolve
  • When an avian virus mutates or changes.
  • From a combination of an avian and human virus.
  • If the new strain infects humans and is able to
    spread easily from person to person
  • Humans would have little or no immunity.
  • It would rapidly travel around the world and
    cause high levels of disease and death.
  • Pandemic global outbreak of disease
  • Occur naturally at variable intervals.
  • Are not always severe.

20
Origins of Pandemic Influenza
Belshe RB. N Engl J Med. 2005 3532209-11
21
20th Century Influenza Pandemics
  • 1918-19 Spanish flu A (H1N1)
  • Most severe pandemic known.
  • New influenza virus subtype emerged and spread
    around the globe in 4 - 6 months.
  • 20-50 million deaths worldwide.
  • 500 - 650,000 deaths in the U.S.
  • Ten times as many Americans died of influenza
    than died in World War I.

22
20th Century Influenza Pandemics
  • 1957-58 - Asian flu A (H2N2)
  • First identified in China in late Feb 1957.
  • Spread to the U.S. by June (4 months).
  • 70,000 deaths in the U.S.
  • 1968-69 - Hong Kong flu A (H3N2)
  • Detected in Hong Kong in early 1968.
  • Spread to U.S. later that year.
  • 34,000 deaths in the U.S.
  • H3N2 continues to circulate.

23
Influenza Pandemics Summary
  • Pandemics vary in severity.
  • Not possible to predict in advance how severe the
    next pandemic will be, but we know from history
    that they can be severe.
  • Not possible to know in advance when the next
    pandemic will occur.
  • When it does occur, it will spread rapidly.

24
(No Transcript)
25
National Strategy
  • Stop, slow or otherwise limit the spread of a
    pandemic to the United States.
  • Limit the domestic spread of a pandemic, and
    mitigate disease, suffering and death.
  • Sustain infrastructure and mitigate impact to the
    economy and the functioning of society.

26
U.S. Planning Assumptions
  • Attack rate 35 of population
  • Treatment rate 25 of population
  • Hospitalization rate 10 of cases
  • Case fatality rate 2 (2 - 50)
  • Pre/asymptomatic 30 - 50 (?)
  • transmission
  • Reproduction number 2 people (0 21 people)
  • Incubation period 2 days (1 8 days)

27
HHS Assumptions
28
HHS Assumptions
29
SC DHEC Assumptions
  • Infection rate
  • Ranging from 15 to 30
  • Outpatient care
  • 500,000 1.200,000
  • Hospitalizations
  • 7,000 - 17,000
  • Deaths
  • 2,000 5,000

30
Outbreak Control Tools
  • Infection control
  • Isolation
  • Quarantine
  • Social distancing
  • Sheltering in place
  • Antivirals
  • Vaccines

31
Phases, Stages and Categories
  • Phases (WHO)
  • Global Risk.
  • Stages (US Government Response)
  • Immediate and specific threat a pandemic virus
    poses to the US population.
  • Categories (HHS/CDC)
  • Severity index (think hurricanes).

32
WHO Phases
(WHO. 2007)
33
US Stages
(CDC. Feb 2007)
34
CDC Severity Index
(CDC. Feb 2007)
35
(No Transcript)
36
Human Influenza Vaccine
  • Influenza virus is continually changing
  • Allows virus to evade the immune system.
  • Flu vaccine must be made yearly
  • Based on best projection of the types of
    influenza virus that will be circulating.

37
Human Influenza Vaccine
  • Vaccination is one of the most effective ways to
    minimize suffering and death from influenza.
  • Research has developed a vaccine for one strains
    of the H5N1 influenza virus in humans.
  • The US Government is working to expand domestic
    influenza vaccine production capacity.
  • However, the scarcity of pre-pandemic and
    pandemic influenza vaccine will require that the
    limited supply be allocated or prioritized for
    distribution and administration.

38
National Strategy - Vaccines
(CDC. Feb 2007)
39
Antivirals
  • Relenza (zanamivir)
  • FDA Approved for
  • Persons aged 7 years and older for treatment of
    uncomplicated influenza illness.
  • Treatment of type A and B influenza.
  • Preventive use, to decrease the risk of
    developing influenza illness, for persons aged 5
    and older.
  • For the drug to be effective, treatment needs to
    be started within two days of the onset of
    symptoms.
  • An inhaled powder.
  • Relenza is not recommended for people with
    underlying respiratory disease.
  • Relenza is not a substitute for influenza vaccine.

40
Antivirals
  • Tamiflu (oseltamivir phosphate)
  • FDA approved for
  • The treatment of uncomplicated influenza in
    patients one year and older whose flu symptoms
    have not lasted more than two days.
  • Approved to treat Type A and B influenza.
  • Also approved for the prevention of influenza in
    adults and children aged one year and older. 
  • Oral administration
  • Efficacy of Tamiflu in the treatment of influenza
    in subjects with chronic cardiac disease and/or
    respiratory disease has not been established.

41
Human Influenza Vaccine
  • A tiered allocation for vaccines in severe
    pandemics is being proposed with the following
    objectives considered to be the most important
  • Protect those who are essential to the pandemic
    response and provide care for persons who are
    ill.
  • Protect those who maintain essential community
    services.
  • Protect children.
  • Protect workers who are at greater risk of
    infection as a result of their job.
  • Protect those who maintain homeland and national
    security.

42
Vaccine Allocation
(DHHS. DHS. 23 July 2008)
43
Vaccine Allocation
(DHHS. DHS. 23 July 2008)
44
Vaccine Allocation
(DHHS. DHS. 23 July 2008)
45
Key Strategy
46
Healthcare Planning
  • Clinical Care
  • Communications
  • Leadership
  • Operations
  • Legal
  • Employee Health
  • Psychosocial
  • Human Resources
  • Logistics
  • Supply Chain
  • Finance
  • Ethical

47
On-Going Planning Issues
  • Community Interventions
  • Hospital Planning Support
  • Alternate Medical Treatment Sites
  • Altered Standards of Care

48
Building a Pandemic Plan ? Recovery
Build Pandemic Response Plan
Stabilize Operations, Recover and Prepare for
Next Wave
Activate Plan and Manage Problems
Communicate and Exercise
Monitor
Inter-Pandemic Period
Pandemic Alert Period
PANDEMIC PERIOD
Time Between Waves
49
Post Test
  • How Does Your Community Plan To Address The Needs
    Created By An Influenza Pandemic?
  • Call in FEMA
  • We Have No Plan
  • We Have Created A Plan Specifically For Avian
    Influenza
  • Not Sure

50
Post Test
  • How Does Your Community Plan To Address The Needs
    Created By An Influenza Pandemic?
  • Call in FEMA
  • We Have No Plan
  • We Have Created A Plan Specifically For Avian
    Influenza
  • Not Sure

51
Q A
  • Thank You!
Write a Comment
User Comments (0)
About PowerShow.com